Magtein is a patented form of magnesium designed to effectively deliver magnesium to the brain and is supported by an expanding body of clinical research exploring its role in cognitive health, sleep quality, and neurological function.
Through this partnership, IGEA Nutrition will collaborate with nutraceutical brands, product developers, and manufacturers across the ANZ region to support the launch, formulation, and commercial integration of Magtein in finished dietary supplement and functional nutrition products.
ThreoTech is the exclusive global supplier and patent licensee for Magtein, responsible for advancing research, quality assurance, and international commercialization of the ingredient.
IGEA Nutrition is a global provider of research-backed nutritional solutions for the food and nutraceutical industries, combining scientific expertise with efficient supply and distribution capabilities. The company focuses on delivering high-quality, validated ingredients supported by robust research and transparent sourcing.
The company was founded in 2025 by Peter Schwarczer, a nutraceutical industry professional with more than 18 years of experience in ingredient commercialization, international business development, and strategic partnerships within the global dietary supplement sector.
“ANZ represents a highly sophisticated and innovation-driven nutraceutical market,” said Schwarczer. “Our goal at IGEA Nutrition is to work closely with brands and manufacturers to support the responsible and science-based introduction of Magtein across the region.”
As part of its market development strategy, IGEA Nutrition plans to showcase Magtein at several key industry events in Australia and New Zealand, providing opportunities for education, networking, and collaboration with regional nutraceutical stakeholders.
These include participation in industry gatherings such as the Natural Health Products New Zealand Summit 2026, a major three-day industry event bringing together local and international experts for knowledge sharing, networking, and exhibitions.
The company also plans engagement with events organized by the Complementary Medicines Australia (CMA) community, including the CMA Innovation Day in Sydney.
With consumer demand continuing to grow for cognitive health, sleep, and healthy ageing solutions, the expansion marks an important step in strengthening Magtein’s presence in key international nutraceutical markets.
About IGEA Nutrition
IGEA Nutrition is an innovative ingredient solutions and market development company serving the global nutraceutical and food industries. The company partners with leading brands to deliver research-backed ingredients, supporting product development, commercialization, and supply. Founded by industry experts, IGEA Nutrition combines scientific expertise with strategic market insight to advance high-quality, clinically supported nutritional solutions. Contact: pete@igeanutrition.com
About ThreoTech, LLC
ThreoTech, LLC is an innovative manufacturing, marketing, and research company that was created as a spinoff from AIDP to promote the power of Magtein. ThreoTech, LLC is the exclusive global ingredient supplier and patent licensee for Magtein®, ensuring its quality and authenticity.
About Magtein
Magtein is the branded form of magnesium L-threonate, developed by researchers in 2010 to help address the challenge of increasing magnesium levels in the brain. Magtein supports brain health, healthy cognitive aging, focus, mood, sleep quality, heart rate variability, and reaction time, based on findings from multiple human clinical studies.* Today, Magtein is used in over 400 products by partner brands globally and continues to be clinically studied. Magtein is stable, tasteless, odorless, colorless, and water-soluble, with applicability across capsules and tablets, as well as gels, powders, and liquids.
